Papers
9
Total Citations
249
H-Index
6
About
Boris Gershman is a urologic oncologist and health services researcher whose work sits at the intersection of surgical innovation, outcomes research, and health policy. His primary research areas include the volume-outcome relationship in robotic surgery, comparative effectiveness of minimally invasive versus open urologic oncology procedures, and perioperative quality improvement. Gershman’s most influential work, a 2017 study on robot-assisted radical prostatectomy with 71 citations, critically redefines how centralization of care should be evaluated for robotic surgery, challenging conventional assumptions about hospital volume thresholds. He has also made significant contributions to understanding thromboembolic prophylaxis compliance among urologists (48 citations) and the comparative morbidity and costs of robotic versus laparoscopic nephrectomy (42 citations). His research consistently leverages large national datasets like NSQIP to provide real-world evidence on surgical outcomes. Notably, Gershman has also ventured into translational research, exploring pH-targeted peptide therapies for bladder cancer using pHLIP technology. His work has been published in leading urology journals and has informed both clinical practice guidelines and health policy discussions around surgical centralization and quality measurement.
Research Focus
Key Achievements
Top Papers
- 1
- 2
- 3
- 4
- 5
- 6
- 7
- 8
- 9